Get the Stockscreener App
3.35
0.00%
0.00
After Hours:
3.37
0.02
+0.60%
Grace Therapeutics Inc stock is traded at $3.35, with a volume of 27,389.
It is up +0.00% in the last 24 hours and up +6.01% over the past month.
Grace Therapeutics Inc is a late-stage specialty pharma company with drug delivery technologies and drug candidates addressing rare and orphan diseases. The company's lead drug candidate, GTx-104, is a novel injectable formulation of nimodipine for the treatment of a rare disease, aneurysmal subarachnoid hemorrhage. Other products are GTx-102 Ataxia-Telangiectasia, GTx-101 Postherpetic Neuralgia, and GTx-201.
See More
Previous Close:
$3.35
Open:
$3.44
24h Volume:
27,389
Relative Volume:
0.42
Market Cap:
$51.84M
Revenue:
-
Net Income/Loss:
$-10.31M
P/E Ratio:
-4.3506
EPS:
-0.77
Net Cash Flow:
$-12.65M
1W Performance:
-0.30%
1M Performance:
+6.01%
6M Performance:
+9.12%
1Y Performance:
-11.84%
1-Day Range:
$3.33
$3.44
1-Week Range:
$3.24
$3.4764
52-Week Range:
$1.75
$4.685
Grace Therapeutics Inc Stock (GRCE) Company Profile
Name
Grace Therapeutics Inc
Sector
Industry
Phone
609-322-1602
Address
103 CARNEGIE CENTER, PRINCETON
Compare GRCE with other stocks
| Stocks | Price | Market Cap | Revenue | Net Income | Cash Flow | EPS |
|---|---|---|---|---|---|---|
GRCE
Grace Therapeutics Inc
|
3.35 | 51.84M | 0 | -10.31M | -12.65M | -0.77 |
|
VRTX
Vertex Pharmaceuticals Inc
|
447.38 | 114.05B | 11.74B | 3.68B | 3.34B | 14.19 |
|
REGN
Regeneron Pharmaceuticals Inc
|
748.71 | 78.80B | 14.25B | 4.58B | 3.88B | 41.77 |
|
ALNY
Alnylam Pharmaceuticals Inc
|
396.04 | 51.80B | 3.21B | 43.57M | 221.36M | 0.2405 |
|
ARGX
Argen X Se Adr
|
847.05 | 53.08B | 3.06B | 1.28B | 447.35M | 19.67 |
|
INSM
Insmed Inc
|
166.55 | 42.33B | 447.02M | -1.18B | -906.14M | -6.1812 |
Grace Therapeutics Inc Stock (GRCE) Upgrades & Downgrades
| Date | Action | Analyst | Rating Change |
|---|---|---|---|
| May-02-25 | Initiated | TD Cowen | Buy |
| Sep-01-20 | Downgrade | Oppenheimer | Outperform → Perform |
| Jul-06-20 | Upgrade | B. Riley FBR | Neutral → Buy |
| Jan-13-20 | Downgrade | B. Riley FBR | Buy → Neutral |
| Aug-29-19 | Initiated | B. Riley FBR | Buy |
| Jul-18-19 | Initiated | Oppenheimer | Outperform |
| Jun-26-19 | Initiated | H.C. Wainwright | Buy |
View All
Grace Therapeutics Inc Stock (GRCE) Latest News
Is Grace Therapeutics Inc. stock positioned for long term growthJuly 2025 Institutional & Free Technical Pattern Based Buy Signals - Улправда
Stock Analysis: Bullish Pattern Emerging on Entero Healthcare Solutions Limited (ENTERO)2025 Momentum Check & Consistent Return Strategy Ideas - Bollywood Helpline
Moving Average Crossover Confirms Uptrend in Kalyani Investment Company LimitedPrice-to-Earnings Ratio Insights & Affordable Stock Market Tips - Bollywood Helpline
Charles River Extends Commitment to Advanced Therapy Developers with Second Incubator Program Cohort - pharmiweb.com
Winners Losers: Why retail investors favor Grace Therapeutics Inc stock2025 Volume Leaders & Trade Opportunity Analysis - moha.gov.vn
Grace and Molecule.one to Transform Peptide Building Block Synthesis with AI and Automation - Yahoo Finance
Is Grace Therapeutics Inc. stock attractive for long term wealth buildingIPO Watch & Safe Capital Preservation Plans - Newser
Why Grace Therapeutics Inc. stock is popular among millennials2025 Retail Activity & Stepwise Trade Execution Plans - Newser
Grace Therapeutics (GRCE) Stock Analysis Report | Financials & Insights - Benzinga
Is Grace Therapeutics Inc. stock supported by strong fundamentalsTreasury Yields & Short-Term High Return Ideas - moha.gov.vn
What analysts say about Grace Therapeutics Inc stockHigh Frequency Trading Trends & Access High Yield Alerts - earlytimes.in
Why retail investors pile into Grace Therapeutics Inc. stockJuly 2025 Fed Impact & Technical Buy Zone Confirmations - newser.com
Why Grace Therapeutics Inc. stock could rally in 2025Short Setup & Safe Entry Momentum Stock Tips - newser.com
Using RSI to spot recovery in Grace Therapeutics Inc.Trend Reversal & Low Volatility Stock Recommendations - newser.com
Will Grace Therapeutics Inc. stock maintain growth storyWeekly Gains Report & Expert Approved Trade Ideas - newser.com
Will Grace Therapeutics Inc. stock outperform Nasdaq index - newser.com
Can Grace Therapeutics Inc. stock rebound after recent weakness2025 Institutional Moves & Fast Momentum Stock Entry Tips - newser.com
Will Grace Therapeutics Inc. stock outperform value stocks2025 Price Targets & Free Technical Confirmation Trade Alerts - newser.com
Grace Therapeutics Inc. stock outlook for YEARMarket Performance Summary & Community Consensus Picks - newser.com
Kempinski Grace Bay Breaks Ground on Turks and Caicos' Iconic Grace Bay Beach - Yahoo Finance
Building trade automation scripts for Grace Therapeutics Inc.July 2025 Catalysts & Risk Adjusted Buy/Sell Alerts - newser.com
Grace Therapeutics to Participate in 16th Annual Craig-Hallum Alpha Select Conference - The Manila Times
Grace Therapeutics (Nasdaq: GRCE) joins Craig-Hallum 16th Alpha Select Conference - Stock Titan
Grace Therapeutics Inc Stock (GRCE) Financials Data
Revenue
Net Income
Cash Flow
EPS
0.31%
0.33%
Open in Yahoo
|
Open in Google
|
Open in Finviz
|
Open in MarketWatch
|
Open in EDGAR
|
Open in Reuters
Cap:
|
Volume (24h):